Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-01-09, Stock:LLY, The news for the past five days is as follows:
2018-01-02: NEWS1: Lilly to Present at J.P. Morgan Healthcare Conference.NEWS2: Eli Lilly’s Elanco in 3Q17.NEWS3: Eli Lilly’s Neuroscience Products Portfolio in 3Q17.NEWS4: Eli Lilly’s Oncology Products Portfolio in 3Q17.
2018-01-03: NEWS1: Merck's Keytruda Gets Approved for Bladder Cancer in Japan.NEWS2: 3 Stocks That Feel Like Microsoft in 1986.NEWS3: Analysts’ Recommendations for Eli Lilly in December 2017.NEWS4: Analysts’ Estimates for Eli Lilly.
2018-01-04: NEWS1: How Is Novo Nordisk’s New Generation Insulin Segment Positioned after 3Q17?.NEWS2: XLV, AMGN, GILD, LLY: Large Outflows Detected at ETF.NEWS3: Eli Lilly To Participate In Goldman Sachs Healthcare Conference At 8:00 AM ET.NEWS4: Eli Lilly To Participate In Goldman Sachs Healthcare Conference At 8:00 AM ET.
2018-01-05: NEWS1: A Look at Pfizer’s Valuation.NEWS2: Argus Shares Eli Lilly's Optimism, Upgrades To Buy.NEWS3: The Slow Push Upward Continues for Johnson & Johnson Stock.NEWS4: How Did Novo Nordisk’s Victoza and Saxendra Perform in 3Q17?.NEWS5: Lilly Confirms Date and Conference Call for Fourth-Quarter 2017 Financial Results Announcement.NEWS6: The Slow Push Upward Continues for Johnson & Johnson Stock.NEWS7: How Did Novo Nordisk’s Modern Insulin Segment Perform in 3Q17?.
2018-01-08: NEWS1: Eli Lilly CEO Says Tax Reform May Lead to More Successful Deals.NEWS2: Pfizer to Stall R&D for Alzheimer's/Parkinson's, Cut Jobs.NEWS3: Celgene deal could be the first of many for biopharma as new tax law frees up cash.NEWS4: Eli Lilly CEO: It's a great time for science in pharma se....NEWS5: Alzheimer's takes Another Hit as Pfizer Ends Research in this Area.NEWS6: Pfizer to Stall R&D for Alzheimer&apos;s/Parkinson&apos;s, Cut Jobs.NEWS7: Ozempic Could Boost Novo Nordisk’s Revenue Growth in 2018.NEWS8: Livongo and Lilly Collaborate on Real-World Diabetes Research.NEWS9: Alzheimer&apos;s takes Another Hit as Pfizer Ends Research in this Area.

Answer: Decrease